These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34253777)

  • 21. The effect of ABO and Rh blood type on the response to intravenous immune globulin (IVIG) in children with immune thrombocytopenic purpura (ITP).
    Sturgill MG; Nagabandi SR; Drachtman RA; Ettinger AG; Rubin J; Ettinger LJ
    J Pediatr Hematol Oncol; 1997; 19(6):523-5. PubMed ID: 9407938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
    Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
    Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura.
    Demircioğlu F; Saygi M; Yilmaz S; Oren H; Irken G
    Pediatr Hematol Oncol; 2009; 26(7):526-32. PubMed ID: 19863209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better?
    Aronis S; Platokouki H; Mitsika A; Haidas S; Constantopoulos A
    Pediatr Hematol Oncol; 1994; 11(5):487-98. PubMed ID: 7826845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
    Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J;
    Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
    Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA;
    Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
    Celik M; Bulbul A; Aydogan G; Tugcu D; Can E; Uslu S; Dursun M
    J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.
    Kühne T; Buchanan GR; Zimmerman S; Michaels LA; Kohan R; Berchtold W; Imbach P; ;
    J Pediatr; 2003 Nov; 143(5):605-8. PubMed ID: 14615730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic thrombocytopenic purpura in Egyptian children.
    Khalifa AS; Tolba KA; el-Alfy MS; Gadallah M; Ibrahim FH
    Acta Haematol; 1993; 90(3):125-9. PubMed ID: 8291370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I; Henter JI; Elinder G
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune thrombocytopenic purpura in childhood: a Lebanese perspective.
    Moussalem M; Yassine N
    Mol Immunol; 2003 Jul; 39(17-18):1105-7. PubMed ID: 12835086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus can make immune thrombocytopenic purpura refractory.
    DiMaggio D; Anderson A; Bussel JB
    Br J Haematol; 2009 Jun; 146(1):104-12. PubMed ID: 19438507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of intravenous immunoglobulin (Flebogamma
    Apte S; Navarro-Puerto J; Damodar S; Ramanan V; John J; Kato G; Ross C; Shah C; Torres M; Fu C'; Rucker K; Pinciaro P; Barrera G; Aragonés ME; Ayguasanosa J
    Immunotherapy; 2019 Feb; 11(2):81-89. PubMed ID: 30499734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A for persistent or chronic immune thrombocytopenia in children.
    Liu AP; Cheuk DK; Lee AH; Lee PP; Chiang AK; Ha SY; Tsoi WC; Chan GC
    Ann Hematol; 2016 Oct; 95(11):1881-6. PubMed ID: 27525725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
    Blackhouse G; Xie F; Levine MA; Campbell K; Assasi N; Gaebel K; O'Reilly D; Tarride J; Goeree R
    J Popul Ther Clin Pharmacol; 2012; 19(2):e166-78. PubMed ID: 22580389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.